1 / 4

Structural heart devices market

Structural heart devices market is expected to reach US$ 15.5Bn by 2026 at a CAGR of 10.5% during the forecast period.

rdagade
Télécharger la présentation

Structural heart devices market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Structural heart devices market is expected to reach US$ 15.5Bn by 2026 at a CAGR of 10.5% during the forecast period. The structural heart devices market has gained weight in recent years due to the uncompromising rise in mitral regurgitation, aortic stenosis, and other related heart diseases. A rise in the incidence of aortic stenosis, increase in awareness about the benefits and availability of structural heart devices worldwide, and the introduction of technologically advanced products (such as the Trifecta valve with Glide Technology) has driven the market demand of structural heart devices market. Healthcare expenditure and the growing geriatric population is expected to create market opportunities for the structural heart devices in the future as well. Furthermore, stringent approval process and a high cost of surgeries may hamper the growth of the market acting as some of the major restraints for the market growth. Structural heart devices market Structural heart devices market is segmented by product, procedure, and region. Among procedures, surgical aortic valve replacement (SAVR), transcatheter aortic valve replacement (TAVR) segment market accounted for the largest share in 2016. Surgical aortic valve replacement dominated in 2016 due to its proved efficacy in the treatment and established reimbursement codes. Based on products, surgical heart valves product is expected to be one of the fastest growing segments in the forecast period. The minimally invasive surgical nature of the procedure is the key reason for this rapid growth. Among regions, the North America region is expected to grow at the highest CAGR during the forecast period due to a high prevalence of cardiovascular disease, increasing adoption of angiographic procedures and rising demand of accurate diagnosis. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period due to the increasing awareness of cardiac diseases, better newborn screening programs, and improvement in healthcare access. The key players of the Structural Heart Devices Market include Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova plc (UK). There is a sturdy growth in the production as new companies are entering the structural heart market. For example, in May 2016, a leading medical devices company, Edwards Lifesciences Corporation (US) announced its intentions to enter the structural heart market.

  2. In the structural heart devices market, Boston Scientific Corporation holds the leadership position due to production capacity expansion, brand portfolio expansion, mergers, collaborations, and acquisitions. In 2018, the company has adopted new product launches, product enhancements, and geographic expansion as its crucial business plans to certify its dominance in this market. For More Information Visit https://www.maximizemarketresearch.com/market-report/structural-heart-devices-market/13692/ The scope of Structural Heart Devices Market report: • Structural Heart Devices Market, by Product • Heart Valve Devices • Surgical Heart Valves • Transcatheter Heart Valves • Occluders and Delivery Systems • Annuloplasty Rings • Other Devices • Accessories • Structural Heart Devices Market, by Procedure • Replacement Procedures • TAVR Procedures • SAVR Procedures • Repair Procedures • Closure Procedures • Annuloplasty • Valvuloplasty • TMVR Procedures • Structural Heart Devices Market, By Region • North America

  3. • Europe • APAC • Latin America • MEA • Key Players, Structural Heart Devices Market • Edwards Lifesciences Corporation • Medtronic plc • Abbott • Boston Scientific Corporation • LivaNova plc (UK). • ST.JUDEMEDICAL • Biomerics, • Comed BV • LivaNova PLC • JenaValve Technology, Inc. • CardioKinetix This Report Is Submitted By @Maximize Market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities. About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: Lumawant Godage Organization: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com

  4. Address:Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India. Contact: +919607195908

More Related